Trusted sourcing partnerBest Pharma Supplier
Best PharmaFINISHED DOSAGE PORTFOLIO
Explore Decure’s sourcing portfolio across injectables, tablets, capsules, dry syrups, topical formulations and specialized therapeutic ranges, with multiple strengths, compositions and dosage-form options for institutional and commercial requirements.
BROWSE BY DOSAGE & THERAPY
Sterile injectable formulations for institutional and hospital requirements.
Beta-Lactam and Non-Beta-Lactam formulations across therapeutic categories.
Hard-shell capsule formulations in multiple strengths and compositions.
Paediatric and adult oral liquid and dry-syrup formulation options.
Creams, ointments and other topical dosage-form requirements.
Formulations supporting diabetes-management sourcing requirements.
Cardiovascular formulations across common dosage forms and strengths.
PRODUCT FINDER
Non-Beta-Lactam Tablets
TabletsAceclofenac 100 mg + Paracetamol 325 mg + Chlorzoxazone 250 mg Tablet is a tablet formulated with Aceclofenac 100 mg + Paracetamol 325 mg + Chlorzoxazone 250 mg. The active ingredient profile is Aceclofenac; Paracetamol; Chlorzoxazone, placing the product
TabletsAceclofenac 100 mg + Paracetamol 325 mg + Chlorzoxazone 500 mg Film-Coated Tablet is a film-coated tablet formulated with Aceclofenac 100 mg + Paracetamol 325 mg + Chlorzoxazone 500 mg. The active ingredient profile is Aceclofenac; Paracetamol; Chlorzoxaz
TabletsAceclofenac 100 mg + Paracetamol 325 mg + Chlorzoxazone 500 mg Uncoated Tablet is a uncoated tablet formulated with Aceclofenac 100 mg + Paracetamol 325 mg + Chlorzoxazone 500 mg. The active ingredient profile is Aceclofenac; Paracetamol; Chlorzoxazone, p
TabletsAceclofenac 100 mg + Paracetamol 325 mg + Serratiopeptidase 10 mg Film-Coated Tablet is a film-coated tablet formulated with Aceclofenac 100 mg + Paracetamol 325 mg + Serratiopeptidase 10 mg. The active ingredient profile is Aceclofenac; Paracetamol; Serr
TabletsAceclofenac 100 mg + Paracetamol 325 mg + Thiocolchicoside 4 mg Film-Coated Tablet is a film-coated tablet formulated with Aceclofenac 100 mg + Paracetamol 325 mg + Thiocolchicoside 4 mg. The active ingredient profile is Aceclofenac; Paracetamol; Thiocolc
TabletsAceclofenac 100 mg + Paracetamol 325 mg + Trypsin-Chymotrypsin 150,000 IU Tablet is a tablet formulated with Aceclofenac 100 mg + Paracetamol 325 mg + Trypsin-Chymotrypsin 150,000 IU. The active ingredient profile is Aceclofenac; Paracetamol; Trypsin-Chym
TabletsAceclofenac 100 mg + Paracetamol 325 mg + Trypsin-Chymotrypsin 50,000 AU Film-Coated Tablet is a film-coated tablet formulated with Aceclofenac 100 mg + Paracetamol 325 mg + Trypsin-Chymotrypsin 50,000 AU. The active ingredient profile is Aceclofenac; Par
TabletsAceclofenac 100 mg + Paracetamol 325 mg Film-Coated Tablet is a film-coated tablet formulated with Aceclofenac 100 mg + Paracetamol 325 mg. The active ingredient profile is Aceclofenac; Paracetamol, placing the product in the nsaid + analgesic combination
TabletsAceclofenac 100 mg + Paracetamol 325 mg Uncoated Tablet is a uncoated tablet formulated with Aceclofenac 100 mg + Paracetamol 325 mg. The active ingredient profile is Aceclofenac; Paracetamol, placing the product in the nsaid + analgesic combination categ
TabletsAceclofenac 100 mg + Thiocolchicoside 4 mg Film-Coated Tablet is a film-coated tablet formulated with Aceclofenac 100 mg + Thiocolchicoside 4 mg. The active ingredient profile is Aceclofenac; Thiocolchicoside, placing the product in the nsaid + muscle rel
TabletsAceclofenac 100 mg + Tizanidine 2 mg Film-Coated Tablet is a film-coated tablet formulated with Aceclofenac 100 mg + Tizanidine 2 mg. The active ingredient profile is Aceclofenac; Tizanidine, placing the product in the nsaid + centrally acting muscle rela
TabletsAceclofenac 100 mg Film-Coated Tablet is a film-coated tablet formulated with 100 mg. The active ingredient profile is Aceclofenac, placing the product in the nsaid / analgesic anti-inflammatory category. The formulation contains an NSAID and/or non-opioi
TabletsAceclofenac 200 mg + Pregabalin 75 mg Enteric-Coated Tablet is a enteric-coated tablet formulated with Aceclofenac 200 mg + Pregabalin 75 mg. The active ingredient profile is Aceclofenac; Pregabalin, placing the product in the nsaid + neuropathic pain age
TabletsAceclofenac Sustained-Release 200 mg Film-Coated Tablet is a sustained-release film-coated tablet formulated with 200 mg. The active ingredient profile is Aceclofenac, placing the product in the nsaid / analgesic anti-inflammatory category. The formulatio
TabletsBetahistine Hydrochloride 8 mg Uncoated Tablet is a uncoated tablet formulated with 8 mg. The active ingredient profile is Betahistine Hydrochloride, placing the product in the antivertigo agent category. Betahistine is an antivertigo medicine used in sel
TabletsCarbamazepine 200 mg Uncoated Tablet is a uncoated tablet formulated with 200 mg. The active ingredient profile is Carbamazepine, placing the product in the anticonvulsant / neuropathic pain agent category. Carbamazepine is an anticonvulsant that also has
TabletsDeflazacort 12 mg Film-Coated Tablet is a film-coated tablet formulated with 12 mg. The active ingredient profile is Deflazacort, placing the product in the corticosteroid category. Deflazacort is a systemic corticosteroid with anti-inflammatory and immun
TabletsDeflazacort 6 mg Uncoated Tablet is a uncoated tablet formulated with 6 mg. The active ingredient profile is Deflazacort, placing the product in the corticosteroid category. Deflazacort is a systemic corticosteroid with anti-inflammatory and immunosuppres
TabletsDiclofenac 50 mg + Paracetamol 325 mg + Trypsin-Chymotrypsin 50,000 AU Film-Coated Tablet is a film-coated tablet formulated with Diclofenac 50 mg + Paracetamol 325 mg + Trypsin-Chymotrypsin 50,000 AU. The active ingredient profile is Diclofenac; Paraceta
TabletsDiclofenac Potassium 50 mg + Acetaminophen 325 mg + Chlorzoxazone 250 mg Uncoated Tablet is a uncoated tablet formulated with Diclofenac Potassium 50 mg + Acetaminophen 325 mg + Chlorzoxazone 250 mg. The active ingredient profile is Diclofenac Potassium;
TabletsDiclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorpheniramine Maleate 4 mg + Magnesium Trisilicate 100 mg Uncoated Tablet is a uncoated tablet formulated with Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorpheniramine Maleate 4 mg + Magnesium
TabletsDiclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorzoxazone 250 mg Film-Coated Tablet is a film-coated tablet formulated with Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorzoxazone 250 mg. The active ingredient profile is Diclofenac Potassium
TabletsDiclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorzoxazone 250 mg Uncoated Tablet is a uncoated tablet formulated with Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chlorzoxazone 250 mg. The active ingredient profile is Diclofenac Potassium; Para
TabletsDiclofenac Potassium 50 mg + Paracetamol 325 mg + Chymotrypsin 50,000 IU Tablet is a tablet formulated with Diclofenac Potassium 50 mg + Paracetamol 325 mg + Chymotrypsin 50,000 IU. The active ingredient profile is Diclofenac Potassium; Paracetamol; Chymo
TabletsDiclofenac Potassium 50 mg + Paracetamol 325 mg + Serratiopeptidase 10 mg Film-Coated Tablet is a film-coated tablet formulated with Diclofenac Potassium 50 mg + Paracetamol 325 mg + Serratiopeptidase 10 mg. The active ingredient profile is Diclofenac Pot
FROM BRIEF TO SUPPLY
Share dosage form, strength, quantity and destination.
We review availability and documentation expectations.
Commercial and supply requirements move forward together.
HUMAN FORMULATIONS
